Skip to main content

Table 1 Drug susceptibility test results

From: Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study

  HR-TB
n = 78
PDR-TB
n = 42
MDR-TB
n = 77
DS-TB
n = 203
R(H) 78 (100%) 0 0 0
R (RH) 0 0 28 (36.4%) 0
R (HES) 0 38 (90.5%) 0 0
R (RHES) 0 0 20 (26.0%) 0
R (RHE) 0 0 15 (19.5%) 0
R (HE) 0 4 (9.5%) 0 0
R (RHS) 0 0 14 (18.2%) 0
S (RHES) 0 0 0 131 (64.5%)
S (R) 0 0 0 72 (35.5%)
  1. R(H): Resistance to Isoniazid; R (RH): resistant to rifampicin and isoniazid; R (HES): resistance to isoniazid, ethambutol and streptomycin; R (RHES): resistance to rifampicin, isoniazid, ethambutol and streptomycin; R (RHE): resistance to rifampicin, isoniazid and ethambutol; R (HE): Resistance to isoniazid and ethambutol; S (RHES): susceptible to rifampicin, isoniazid, ethambutol and streptomycin; S(R): susceptibility to rifampicin by gene xpert
  2. HR-TB Isoniazid mono-resistant tuberculosis, PDR-TB poly drug-resistant tuberculosis, MDR-TB multi drug-resistant tuberculosis, DS-TB drug-susceptible tuberculosis